Abstract Number: 2325 • 2015 ACR/ARHP Annual Meeting
Quantitative Clues to Recognize and Document Comorbid Fibromyalgia in Routine Care of Patients with Other Rheumatic Diagnoses on a 10 Cm Distress Visual Analog Scale Found on 1-Page Physician Rheumetric Checklist
Background/Purpose: A physician global estimate (DOCGL) is commonly used to assess patients with rheumatic diseases. Fibromyalgia (FM) has been reported as a comorbidity in 10-35%…Abstract Number: 1467 • 2015 ACR/ARHP Annual Meeting
Health Related Quality of Life Is Reduced in Pediatric Patients with Juvenile Idiopathic Arthritis and Juvenile-Onset Fibromyalgia
Background/Purpose : A number of validated measures are now available for the evaluation of health related quality of life (HRQOL) in children with rheumatic diseases,…Abstract Number: 2335 • 2015 ACR/ARHP Annual Meeting
How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)
Background/Purpose: Fatigue is an important problem for many patients with rheumatic diseases. Fatigue is associated with disease severity, psychological distress, and a poorer quality of…Abstract Number: 1469 • 2015 ACR/ARHP Annual Meeting
A Comparison of Pain and Disability, and Their Association Between Juvenile Primary Fibromyalgia Syndrome and Pediatric Rheumatic Diseases: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry
Background/Purpose: We aim to determine the extent to which pain severity differs between patients with JPFS and other rheumatic diseases and if the degree of…Abstract Number: 2475 • 2015 ACR/ARHP Annual Meeting
Association Between Fibromyalgia and Suicidal Risk: A Systematic Review and Meta-Analysis
Background/Purpose: Chronic pain conditions are related poor overall health, economic burden, and mental disorders including suicidal ideation (SI), suicide attempts (SA), and completed suicides. Fibromyalgia…Abstract Number: 2287 • 2015 ACR/ARHP Annual Meeting
Evaluation of the Fibromyalgia Rapid Screening Tool (FiRST) Questionnaire to Screen Fibromyalgia Associated with Inflammatory Rheumatic Disease
Background/Purpose: Fibromyalgia (FM) is prevalent in patients with chronic inflammatory rheumatic diseases (CIRd), where it hampers diagnosis and activity assessment. No tool for screening FM…Abstract Number: 2697 • 2015 ACR/ARHP Annual Meeting
Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia
Background/Purpose: The differences between seronegative and seropositive rheumatoid arthritis (RA) have not been widely reported. We performed an electronic health record (EHR)-based phenome-wide association study…Abstract Number: 2291 • 2015 ACR/ARHP Annual Meeting
The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months
Background/Purpose: In a rheumatology office practice, patients with fibromyalgia who improved significantly in their symptoms are seen commonly. We evaluated patients whose pain, fatigue, fibrofog,…Abstract Number: 3086 • 2015 ACR/ARHP Annual Meeting
The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
Background/Purpose: An MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) is a 2 sided, 1 page questionnaire which is completed by patients in…Abstract Number: 2294 • 2015 ACR/ARHP Annual Meeting
Re-Scoring the 2011 Fibromyalgia Survey Criteria to be a Better Surrogate for Pain Centralization
Background/Purpose: The 2011 Fibromyalgia (FM) Survey Criteria is comprised of measures of widespread pain (0-19 body areas) and 6 co-morbid symptoms (scored 0-12). The measure…Abstract Number: 3090 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients
Background/Purpose: The prevalence of fibromyalgia (FM) is 10-20% in rheumatoid arthritis (RA) patients, compared to 2-3% in the general population. Previous studies have shown that…Abstract Number: 70 • 2015 ACR/ARHP Annual Meeting
Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014
Background/Purpose: –The Brazilian registry on fibromyalgia syndrome (EPIFIBRO) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…Abstract Number: 2299 • 2015 ACR/ARHP Annual Meeting
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
Background/Purpose: Although polymorphisms of the catechol-O-methyl transferase (COMT) gene have been implicated in altered pain sensitivity, results concerning the association between COMT gene polymorphisms and…Abstract Number: 3091 • 2015 ACR/ARHP Annual Meeting
A Randomized, Controlled Trial of Pregabalin in Adolescent Patients (12-17 years) with Fibromyalgia
Background/Purpose: :Fibromyalgia (FM) is characterized by chronic widespread pain, sleep disturbance, and fatigue. Pregabalin is approved in the US in adults for the management of…Abstract Number: 76 • 2015 ACR/ARHP Annual Meeting
Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory
Background/Purpose: The objective of this study was to evaluate whether weather had an affect on fibromyalgia symptoms as measured by the Revised Fibromyalgia Impact Questionnaire…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 23
- Next Page »